Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RA Capital
Biotech
Candid scores Nasdaq listing via reverse merger Rallybio
The deal will allow Candid to trade on the Nasdaq while dumping RallyBio’s own rare disease maternal-fetal medicine assets.
Will Maddox
Mar 2, 2026 11:45am
Sensei steps back from brink by finding Faeth merger
Feb 18, 2026 10:33am
ILiAD advances whooping cough vaccine with $115M raise
Feb 10, 2026 8:00am
Corxel secures $287M series D to fund oral GLP-1 studies
Jan 22, 2026 10:22am
Ramaswamy-backed Ambros launches with $125M to develop pain med
Dec 16, 2025 1:32pm
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
